Hereditary Cancer Testing Market

Future Market Insights

Key Insight

The hereditary cancer testing market is projected to grow from USD 5.3 billion in 2025 to USD 19.3 billion by 2035, at a CAGR of 13.8%. Breast Cancer will dominate with a 11.9% market share, while molecular testing will lead the technology outlook segment with a 56.4% share.

September 24, 2025

Anurag Sharma

250 Pages

Cite this Report

Hereditary Cancer Testing Market

https://www.futuremarketinsights.com/reports/hereditary-cancer-testing-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Bio-Rad Laboratories
CSL Limited
T. Rowe Price
Eurofins Scientific
F. Hoffmann-La Roche Ag
Illumina
Invitae Corporation
Myriad Genetics
Qiagen
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Hereditary Cancer Testing Market

Key Players

Similar Industry Reports